It has been reported that there was no significant association between AAA progression and the use of statins, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (Baxter et al., 2008; Kokje et al., 2015), which indicated that there may be other mechanisms involved in the progression of AAA. Here, ACE is linked to triple-A syndrome.